Scaling Up Obesity Care: Conversations about Adolescent Obesity and Treatment
ACPE Activity Number:0204-0000-26-029-H01-P Release Date:03/13/2026 Expiration Date:03/13/2029 Activity Type: Knowledge-based CE Credits: 0.75 contact hour, no partial credit Activity Fee: Member – Free / Non-Member – Not Available
Activity Overview
This episode of Clinical Conversations addresses the growing challenge of adolescent obesity, which now affects over 22% of U.S. teens. The discussion highlights FDA-approved pharmacotherapy options for adolescents, considerations for side effects and monitoring, and the importance of pairing medications with lifestyle interventions. The episode also explores strategies for providing patient-centered, bias-free care and engaging families in long-term weight management.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
These activities were planned to meet the educational needs of pharmacists and other healthcare professionals involved in the management of obesity and weight-related conditions, particularly those practicing in ambulatory care and clinical settings.
After completing this activity, the learner should be able to:
Identify FDA-approved pharmacologic options for adolescents with obesity, along with key considerations for safety, monitoring, and family involvement in care.
Discuss strategies for integrating pharmacotherapy with lifestyle interventions, motivational interviewing, and interdisciplinary collaboration to optimize outcomes in adolescent obesity management.
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.
